SPY332.11+2.05 0.62%
DIA272.00+3.59 1.34%
IXIC10,998.40+57.23 0.52%

Lumos Pharma shares are trading higher after the company announced the sale of its Priority Review Voucher for $100 million.

Benzinga · -